Highlights
NASDAQ: CBAY       Cymabay Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
2.06   +0.34 (19.77%)  1.75 - 2.185  10,119,451

Overview

 
Avg Volume (4 weeks):4,221,332
4 Weeks Range:1.29 - 5.72
4 Weeks Price Volatility (%):
17.38%
52 Weeks Range:1.29 - 14.00
52 Weeks Price Volatility (%):
6.06%
Average Price Target: 15.00
Price Target Upside/Downside: +12.94

Headlines



No recent Headlines for this stock.


Business Background

CymaBay Therapeutics Inc is a part of the healthcare sector based in the United States. Its main business involves the development of therapeutics such as Arhalofenate, MBX-8025, and MBX-2982. These drugs are intended to treat serious metabolic disorders. Arhalofenate is used to treat gout, MBX-2982 is an oral, G-protein coupled receptor agonist being evaluated as a therapeutic agent for patients with Type 2 diabetes and MBX-8025 is a selective agonist for the peroxisome proliferator-activated receptor delta.

  Be the first to like this.
 


 

2692  3016  348  2911 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AMD 41.15-1.44 
 CHK 0.789+0.007 
 DHR 148.52-2.78 
 BAC 34.44-0.24 
 GE 11.34-0.10 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 NIO 2.39+0.12 
 AAPL 275.15+3.69 
Partners & Brokers